Using of anti-CD3 monoclonal antibody activated killer cells(CD3AK) in purging of multi-drug resistant leukemic cell lines and leukemic cells from chronic myelogenous leukemia patients.

doi:10.3969/j.issn.1009-0460.2002.02.018

Home>Articles>Using of anti-CD3 monoclonal antibody activated killer cells(CD3AK) in purging of multi-drug resistant leukemic cell lines and leukemic cells from chronic myelogenous leukemia patients.

DOI: 10.3969/j.issn.1009-0460.2002.02.018

Using of anti-CD3 monoclonal antibody activated killer cells(CD3AK) in purging of multi-drug resistant leukemic cell lines and leukemic cells from chronic myelogenous leukemia patients.

Machine-generated Keywords：

Publication Date：2002-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 124-126 )

CHINESE CLINICAL ONCOLOGY

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2002,7(2)